Ameritas Investment Partners’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,221
Closed -$28K 3110
2020
Q4
$28K Hold
1,221
﹤0.01% 2317
2020
Q3
$12K Hold
1,221
﹤0.01% 2656
2020
Q2
$18K Hold
1,221
﹤0.01% 2407
2020
Q1
$15K Buy
1,221
+605
+98% +$7.43K ﹤0.01% 2357
2019
Q4
$10K Hold
616
﹤0.01% 2753
2019
Q3
$8K Buy
+616
New +$8K ﹤0.01% 2834